References

10.1016/j.meegid.2004.12.003

10.1016/j.meegid.2004.12.003 · External reference

Unresolved reference

External reference

Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis

10.1016/s2213-2600(20)30104-1 · 2020 · External reference

Comparative analyses of nonpathogenic, opportunistic, and totally pathogenic mycobacteria reveal genomic and biochemical variabilities and highlight the survival attributes of Mycobacterium tuberculosis

10.1128/mbio.02020-14 · 2014 · External reference

10.1038/nrmicro1889

10.1038/nrmicro1889 · External reference

The antibiotic resistance crisis: part 1: causes and threats

2015 · External reference

Proteomics of multidrug resistant Mycobacterium tuberculosis clinical isolates: a peep show on mechanism of drug resistance & perhaps more

10.4103/0971-5916.154485 · 2015 · External reference

10.1016/j.tim.2016.03.007

10.1016/j.tim.2016.03.007 · External reference

Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump

10.1007/s15010-004-3097-x · 2004 · External reference

10.1038/ng.1038

10.1038/ng.1038 · External reference

Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease

10.1021/ja504096m · 2014 · External reference

Unresolved reference

2018 · External reference

Whole genome sequencing: a new paradigm in the surveillance and control of human tuberculosis

10.1016/j.tube.2014.12.007 · 2015 · External reference

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

10.1183/13993003.01354-2017 · 2017 · External reference

AmpliBASE MT: a Mycobacterium tuberculosis diversity knowledgebase

10.1093/bioinformatics/bth051 · 2004 · External reference

10.1186/1471-2164-15-308

10.1186/1471-2164-15-308 · External reference

Tuberculosis drug resistance mutation database

10.1371/journal.pmed.1000002 · 2009 · External reference

MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis

10.1186/1471-2105-15-107 · 2014 · External reference

Author Correction: Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis

10.1038/s41598-020-71840-y · 2020 · External reference

In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity

10.1038/srep19848 · 2016 · External reference

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains

2018 · External reference

10.1126/science.aba9102

10.1126/science.aba9102 · External reference

Drug-Resistant Tuberculosis 2020

2020 · External reference

DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability

10.1093/nar/gky300 · 2018 · External reference

10.1056/nejmoa1800474

10.1056/nejmoa1800474 · External reference

10.1371/journal.pcbi.1003440

10.1371/journal.pcbi.1003440 · External reference

10.1093/nar/gkp1019

10.1093/nar/gkp1019 · External reference

10.1093/bioinformatics/btl423

10.1093/bioinformatics/btl423 · External reference

Human non-synonymous SNPs: server and survey

10.1093/nar/gkf493 · 2002 · External reference

10.1038/nmeth0410-248

10.1038/nmeth0410-248 · External reference

10.1093/nar/gkg509

10.1093/nar/gkg509 · External reference

SNAP: predict effect of non-synonymous polymorphisms on function

10.1093/nar/gkm238 · 2007 · External reference

10.1093/nar/gkr363

10.1093/nar/gkr363 · External reference

10.1093/bioinformatics/btw361

10.1093/bioinformatics/btw361 · External reference

10.1093/bioinformatics/btt691

10.1093/bioinformatics/btt691 · External reference

mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance

10.1038/srep29575 · 2016 · External reference

Unresolved reference

External reference

10.1093/nar/28.1.235

10.1093/nar/28.1.235 · External reference

10.1016/j.molcel.2017.03.001

10.1016/j.molcel.2017.03.001 · External reference

10.1126/science.7886450

10.1126/science.7886450 · External reference

10.1074/jbc.m402382200

10.1074/jbc.m402382200 · External reference

Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis

10.1016/j.str.2020.12.008 · 2021 · External reference

Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide

10.1371/journal.pone.0015785 · 2011 · External reference

Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis

10.1073/pnas.1525047113 · 2016 · External reference

10.1016/j.jmb.2006.03.055

10.1016/j.jmb.2006.03.055 · External reference

10.1038/nm1466

10.1038/nm1466 · External reference

10.1007/s10822-013-9644-8

10.1007/s10822-013-9644-8 · External reference

Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs

2010 · External reference

10.1093/nar/gkv951

10.1093/nar/gkv951 · External reference

10.1074/jbc.m707412200

10.1074/jbc.m707412200 · External reference

10.1371/journal.pone.0012245

10.1371/journal.pone.0012245 · External reference

10.1021/jm0306430

10.1021/jm0306430 · External reference

A coarse-grained elastic network atom contact model and its use in the simulation of protein dynamics and the prediction of the effect of mutations

10.1371/journal.pcbi.1003569 · 2014 · External reference

The universal protein resource (UniProt)

2008 · External reference

10.1093/nar/25.17.3389

10.1093/nar/25.17.3389 · External reference

10.1093/nar/gky1131

10.1093/nar/gky1131 · External reference

10.1371/journal.pone.0098983

10.1371/journal.pone.0098983 · External reference

10.1128/aac.39.11.2472

10.1128/aac.39.11.2472 · External reference

Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis

10.1016/j.tube.2009.01.004 · 2009 · External reference

10.1128/aac.46.2.443-450.2002

10.1128/aac.46.2.443-450.2002 · External reference

10.1128/microbiolspec.mgm2-0014-2013

10.1128/microbiolspec.mgm2-0014-2013 · External reference

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis

10.1038/s41598-018-33370-6 · 2018 · External reference

10.1093/jac/dkr566

10.1093/jac/dkr566 · External reference

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates

10.1128/jcm.01947-09 · 2010 · External reference

10.1021/acs.jctc.6b00819

10.1021/acs.jctc.6b00819 · External reference

10.1002/prot.22921

10.1002/prot.22921 · External reference

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex

10.1186/s13073-020-00726-5 · 2020 · External reference

Sequence analysis of fluoroquinolone resistance-associated genes gyrA and gyrB in clinical mycobacterium tuberculosis isolates from patients suspected of having multidrug-resistant tuberculosis in New Delhi, India

10.1128/jcm.00670-16 · 2016 · External reference

10.1080/09168451.2017.1314757

10.1080/09168451.2017.1314757 · External reference

10.2217/fmb-2017-0022

10.2217/fmb-2017-0022 · External reference

10.1093/jac/dkt224

10.1093/jac/dkt224 · External reference

10.1101/gr.128678.111

10.1101/gr.128678.111 · External reference

10.1016/s1473-3099(15)00062-6

10.1016/s1473-3099(15)00062-6 · External reference

Evaluation of whole-genome sequence method to diagnose resistance of 13 anti-tuberculosis drugs and characterize resistance genes in clinical multi-drug resistance Mycobacterium tuberculosis isolates from China

10.3389/fmicb.2019.01741 · 2019 · External reference

10.1371/journal.ppat.0020061

10.1371/journal.ppat.0020061 · External reference

10.1128/iai.70.9.4955-4960.2002

10.1128/iai.70.9.4955-4960.2002 · External reference

Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands

10.1086/317598 · 2000 · External reference

10.1016/j.tube.2013.03.005

10.1016/j.tube.2013.03.005 · External reference

Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar

10.1016/j.jgar.2016.04.008 · 2016 · External reference

10.1016/j.meegid.2012.12.013

10.1016/j.meegid.2012.12.013 · External reference

Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan

10.1186/1471-2334-11-240 · 2011 · External reference

pncA Gene mutations associated with pyrazinamide resistance in drug-resistant tuberculosis, South Africa and Georgia

10.3201/eid2303.161034 · 2017 · External reference

Pyrazinamide resistance and mutation patterns among multidrug-resistant Mycobacterium tuberculosis from Henan Province

10.2147/idr.s260161 · 2020 · External reference

10.1128/jcm.02775-15

10.1128/jcm.02775-15 · External reference

10.1371/journal.pone.0039754

10.1371/journal.pone.0039754 · External reference

Detection of fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates as determined by gyrA/B gene mutation by using PCR technique

10.1016/j.ejcdt.2012.08.003 · 2012 · External reference

Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis

10.1128/aac.06272-11 · 2012 · External reference

Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China

10.1016/j.jinf.2010.05.001 · 2010 · External reference

10.1128/aac.01049-15

10.1128/aac.01049-15 · External reference

Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China

10.21037/jtd.2019.11.03 · 2019 · External reference

10.1111/resp.13393

10.1111/resp.13393 · External reference

10.1099/jmm.0.000493

10.1099/jmm.0.000493 · External reference

10.1186/s12890-020-1172-4

10.1186/s12890-020-1172-4 · External reference

Role of gyrB mutations in pre-extensively and extensively drug-resistant tuberculosis in thai clinical isolates

10.1128/aac.00539-16 · 2016 · External reference

Uncovering the Resistance mechanism of Mycobacterium tuberculosis to rifampicin due to RNA Polymerase H451D/Y/R mutations from computational perspective

10.3389/fchem.2019.00819 · 2019 · External reference

Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis

10.1016/j.jiph.2018.04.005 · 2018 · External reference

Permeability barrier to rifampin in mycobacteria

10.1128/aac.11.5.773 · 1977 · External reference

Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare

10.1093/jac/33.3.661-a · 1994 · External reference

Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolates

10.1016/j.ejmech.2011.10.041 · 2012 · External reference

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis

10.1128/aac.42.7.1853 · 1998 · External reference

Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants

10.1128/aac.00303-06 · 2006 · External reference

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan

10.1099/jmm.0.05045-0 · 2003 · External reference

10.1002/0470867302.ch14

10.1002/0470867302.ch14 · External reference

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

10.1016/0140-6736(93)90417-f · 1993 · External reference

10.1128/jcm.00330-06

10.1128/jcm.00330-06 · External reference

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi

10.4102/ajlm.v6i2.463 · 2017 · External reference

Amino acid preferences at protein binding sites

10.1016/0014-5793(94)00648-2 · 1994 · External reference

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

10.1054/tuld.1998.0002 · 1998 · External reference

Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations

10.1007/s00894-017-3290-3 · 2017 · External reference

10.1128/aac.40.9.2187

10.1128/aac.40.9.2187 · External reference

Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates

2013 · External reference

10.1089/mdr.2004.10.269

10.1089/mdr.2004.10.269 · External reference

Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii

10.1021/bi0115479 · 2001 · External reference

Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis

10.1080/07391102.2016.1277784 · 2018 · External reference

Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China

2012 · External reference

Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance

10.1128/aac.00042-11 · 2011 · External reference

Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones

10.4103/0250-474x.106063 · 2012 · External reference

10.1093/nar/gkl695

10.1093/nar/gkl695 · External reference

10.1042/bj20130538

10.1042/bj20130538 · External reference

10.1111/mmi.12520

10.1111/mmi.12520 · External reference

Hyper-accurate ribosomes inhibit growth

10.1002/j.1460-2075.1984.tb02176.x · 1984 · External reference

10.1128/mmbr.00055-15

10.1128/mmbr.00055-15 · External reference

10.1016/j.molcel.2015.10.019

10.1016/j.molcel.2015.10.019 · External reference

10.1038/ng.2878

10.1038/ng.2878 · External reference

Identification of KasA as the cellular target of an anti-tubercular scaffold

10.1038/ncomms12581 · 2016 · External reference

10.1155/2018/6152014

10.1155/2018/6152014 · External reference

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis

10.1126/science.272.5268.1641 · 1996 · External reference

Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis

2018 · External reference

10.1074/jbc.c111.310847

10.1074/jbc.c111.310847 · External reference

10.1128/jb.182.22.6358-6365.2000

10.1128/jb.182.22.6358-6365.2000 · External reference

10.1371/journal.pone.0155127

10.1371/journal.pone.0155127 · External reference

Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis

10.3389/fcimb.2019.00070 · 2019 · External reference

Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target

10.1016/j.tube.2015.05.004 · 2015 · External reference

10.1128/aac.47.12.3799-3805.2003

10.1128/aac.47.12.3799-3805.2003 · External reference

Determination of the activity of standard anti-tuberculosis drugs against intramacrophage Mycobacterium tuberculosis, in vitro: MGIT 960 as a viable alternative for BACTEC 460

10.1016/j.bjid.2013.12.004 · 2014 · External reference

10.1111/j.1365-2958.1995.tb02238.x

10.1111/j.1365-2958.1995.tb02238.x · External reference

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide

10.1038/s41467-017-00721-2 · 2017 · External reference

A multilaboratory, multicountry study to determine MIC quality control ranges for phenotypic drug susceptibility testing of selected first-line antituberculosis drugs, second-line injectables, fluoroquinolones, clofazimine, and linezolid

10.1128/jcm.01138-16 · 2016 · External reference